Oncolytics Biotech Inc.
NASDAQ:ONCYBiotechnology
+$0.03 today
- Market cap
- $50.41M
- Beta
- 1.08
- P/E (TTM)
- -4.3
- EPS (TTM)
- -$0.32
Volume 0.38M
Average 1.26M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Oncolytics Biotech Inc.
NASDAQ:ONCY
Intrinsic Alpha fair value
Locked
Current Price
$0.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Immix Biopharma, Inc. NASDAQ:IMMX | $675.66M | $8.15 | Not rated | -10.1 | +75.12% |
Surrozen, Inc. NASDAQ:SRZN | $190.52M | $25.48 | Not rated | -0.7 | +123.22% |
Whitehawk Therapeutics Inc NASDAQ:WHWK | $183.00M | $3.21 | Not rated | -2.6 | +56.78% |
Zentalis Pharmaceuticals, Inc. NASDAQ:ZNTL | $157.32M | $2.21 | Not rated | -2.1 | +4.62% |
MacroGenics, Inc. NASDAQ:MGNX | $143.33M | $2.25 | Not rated | -3.6 | +44.53% |
Coya Therapeutics, Inc. NASDAQ:COYA | $92.42M | $3.94 | Not rated | -3.9 | -50.17% |
Clene Inc. NASDAQ:CLNN | $55.15M | $3.88 | Not rated | -2.1 | -60.05% |
Instil Bio, Inc. NASDAQ:TIL | $39.61M | $5.84 | Not rated | -1.1 | -37.76% |
Continue the stock analysis
Jump to another research area for this company.